Indivior Pharmaceuticals, Inc 6-K, filed Sep 6, 2023
Indivior Pharmaceuticals, Inc. (INDV)
About this 6-K
Indivior Pharmaceuticals, Inc filed this 6-K on September 6, 2023.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
Date: September 6, 2023
Commission File Number: 001-37835
Indivior PLC
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
EXHIBIT INDEX
| Exhibit No. |
Description of Exhibit | |
| 99.1 | Announcement sent to the London Stock Exchange on September 6, 2023, titled “Indivior to Participate in Investor Events”. | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Indivior PLC | ||||||
| Date: September 6, 2023 | /s/ Kathryn Hudson | |||||
| Name: Kathryn Hudson | ||||||
| Title: Company Secretary | ||||||
Exhibit 99.1
Indivior To Participate in Upcoming Investor Events
Slough, UK, and Richmond, VA, September 6, 2023 – Indivior PLC (LSE/NASDAQ: INDV) today announced that it will participate in the following investor events:
| • | Morgan Stanley 21st Annual Global Healthcare Conference – New York City |
Mark Crossley, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Monday, September 11th. Mark Crossley will participate in a fireside chat at 10:40 a.m. US EDT. Interested investors should contact their Morgan Stanley representative to schedule a meeting. The fireside chat will be publicly available and can be viewed using the following weblink:
MS Conference Weblink
| • | Jefferies Global Healthcare Fireside Chat Series – Virtual |
Mark Crossley, Chief Executive Officer, will participate in a fireside chat on Friday, September 22nd at 14:00 BST (9:00 a.m. US EST). The fireside chat will be publicly available and can be viewed using the following weblink:
REGISTER
Both events will also be accessible at www.indivior.com under the “Investors” section.
About Indivior
Indivior is a global pharmaceutical company working to help change patients’ lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of substance use disorder (SUD). Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 1,000 individuals globally and its portfolio of products is available in 39 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.
Contact:
Jason Thompson
Vice President, Investor Relations
Tel: 804-402-7123 or jason.thompson@indivior.com
Tim Owens
Director, Investor Relations
Tel: 804-263-3978 or timothy.owens@indivior.com
###